Eden Research (LON:EDEN) Trading Down 3.3% – Should You Sell?

Eden Research plc (LON:EDEN) dropped 3.3% on Friday . The company traded as low as GBX 3.30 ($0.04) and last traded at GBX 3.48 ($0.04). Approximately 450,985 shares traded hands during mid-day trading, a decline of 52% from the average daily volume of 933,021 shares. The stock had previously closed at GBX 3.60 ($0.05).

Eden Research Stock Performance

The company has a debt-to-equity ratio of 1.26, a current ratio of 3.80 and a quick ratio of 2.42. The stock has a 50 day simple moving average of GBX 3.87 and a two-hundred day simple moving average of GBX 3.95. The company has a market cap of £18.56 million, a PE ratio of -12.19 and a beta of 0.92.

Insider Buying and Selling at Eden Research

In related news, insider Alexander John Abrey purchased 540,540 shares of the business’s stock in a transaction dated Tuesday, January 28th. The stock was acquired at an average price of GBX 4 ($0.05) per share, for a total transaction of £21,621.60 ($27,317.25). Also, insider Lykele van der Broek purchased 256,000 shares of the business’s stock in a transaction dated Thursday, February 6th. The shares were bought at an average price of GBX 4 ($0.05) per share, with a total value of £10,240 ($12,937.46). 14.02% of the stock is owned by company insiders.

Eden Research Company Profile

Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.

Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites.